相关实验视频
Updated: May 10, 2026

11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
葡萄糖代谢异常和胰腺癌死亡率
S M Gapstur1, P H Gann, W Lowe
1Department of Preventive Medicine, Northwestern University Medical School, 680 N Lake Shore Dr, Suite 1102, Chicago, IL 60611. sgapstur@northwestern.edu
JAMA
|May 18, 2000
概括
即使没有被诊断为糖尿病的血葡萄糖水平升高,也与胰腺癌死亡风险增加有关. 这表明异常的葡萄糖代谢是胰腺癌发展的重要因素.
科学领域:
- 流行病学 流行病学
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 以前的研究表明,糖尿病患者的胰腺癌风险更高.
- 关于后负载血葡萄糖度与胰腺癌风险之间的关联的数据有限.
- 研究这种联系可以提供关于异常葡萄糖代谢在胰腺癌病因学中的作用的见解.
研究的目的:
- 检查后负载血葡萄糖度和胰腺癌死亡风险之间的独立关联.
- 专注于没有自我报告的糖尿病诊断的个人.
主要方法:
- 采用了前性队列研究设计.
- 从1963年至1973年期间选的84个芝加哥地区组织的员工收集的数据.
- 随访时间平均为25年,胰腺癌死亡率作为主要结局指标.
主要成果:
- 一个显著的趋势 (P=.01) 显示胰腺癌死亡风险增加与更高的负载后血葡萄糖水平.
- 相对风险为1.65,1.60和2.15,与≤6.6mmol/L水平相比,葡萄糖范围逐渐增加.
- 这种联系在男性中更明显;较高的体重指数和血清尿酸也与男性的风险增加相关.
结论:
- 研究结果表明,与异常葡萄糖代谢相关的因素可能对胰腺癌的发展有显著的贡献.
- 这突显了葡萄糖失调在胰腺癌发生中的潜在作用.
相关概念视频
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

